Ashish Bansal (A Bansal)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Neuropathic Pain

Atopic Dermatitis

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

American journal of clinical dermatology

The British journal of dermatology

Dermatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Pamela Guglielmini, B S Kim, I Guillemin, S Rhoten, S Wratten, E Brookes, J T O'Malley, Ashish Bansal, J Msihid, R Thomas, Donia Bahloul
Estimating meaningful change thresholds for Skin Pain-Numeric Rating Scale, Sleep-Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (7) (2024)
Shawn G Kwatra, Gil Yosipovitch, Pamela Guglielmini, Isabelle Guillemin, Jérôme Msihid, Ashish Bansal, Melanie Makhija, Simmi Wiggins, Joseph Zahn, Ryan B Thomas, Donia Bahloul
Responder analysis using clinically meaningful thresholds: Post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Amy S Paller, E C Siegfried, S E Marron, M Clark, N Harris, K Kosa, S Qin, D Whalley, J Chao, Ashish Bansal, C C Chuang, Z Wang
Skin pain and sleep quality numeric rating scales for children aged 6 months to 5 years with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Pamela Guglielmini, B S Kim, I Guillemin, S Rhoten, S Wratten, E Brookes, J T O'Malley, Ashish Bansal, J Msihid, R Thomas, Donia Bahloul
Estimating meaningful change thresholds for Skin Pain-Numeric Rating Scale, Sleep-Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (7) (2024)
Pamela Guglielmini, B S Kim, I Guillemin, S Rhoten, S Wratten, E Brookes, J T O'Malley, Ashish Bansal, J Msihid, R Thomas, Donia Bahloul
Estimating meaningful change thresholds for Skin Pain-Numeric Rating Scale, Sleep-Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (7) (2024)
Pamela Guglielmini, B S Kim, I Guillemin, S Rhoten, S Wratten, E Brookes, J T O'Malley, Ashish Bansal, J Msihid, R Thomas, Donia Bahloul
Estimating meaningful change thresholds for Skin Pain-Numeric Rating Scale, Sleep-Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Andrew Blauvelt, Emma Guttman-Yassky, Amy S Paller, Eric L Simpson, Michael J Cork, Jamie Weisman, John Browning, Weily Soong, Xian Sun, Zhen Chen, Matthew P Kosloski, Mohamed A Kamal, Dimittri Delevry, Chien-Chia Chuang, John T O'Malley, Ashish Bansal
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE). American journal of clinical dermatology 23 (3) (2022)
Ashish Bansal, Eric L Simpson, Amy S Paller, Elaine C Siegfried, Andrew Blauvelt, Marjolein de Bruin-Weller, Jonathan Corren, Lawrence Sher, Emma Guttman-Yassky, Zhen Chen, Nadia Daizadeh, Mohamed A Kamal, Brad Shumel, Paola Mina-Osorio, Leda Mannent, Naimish Patel, Neil M H Graham, Faisal A Khokhar, Marius Ardeleanu
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma. American journal of clinical dermatology 22 (1) (2021)
Eric L Simpson, Amy S Paller, Elaine C Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J Cork, Danielle Marcoux, Rui Huang, Zhen Chen, Ana B Rossi, Brad Shumel, Debra Sierka, Ashish Bansal
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older. Dermatology and therapy 11 (5) (2021)
Yan Zhao, L Wu, Q Lu, X Gao, X Zhu, Xu Yao, Lin-Feng Li, Wei Li, Y Ding, Z Song, L Liu, N Dang, C Zhang, X Liu, J Gu, J Wang, Songmei Geng, Q Liu, Y Guo, L Dong, H Su, L Bai, J T O'Malley, J Luo, E Laws, L Mannent, M Ruddy, N Amin, Ashish Bansal, T Ota, M Wang, J Zhang
The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study. The British journal of dermatology (2021)
Elaine C Siegfried, Thomas Bieber, Eric L Simpson, Amy S Paller, Lisa A Beck, Mark Boguniewicz, Lynda C Schneider, Faisal A Khokhar, Zhen Chen, Randy Prescilla, Paola Mina-Osorio, Ashish Bansal
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial. American journal of clinical dermatology 22 (2) (2021)
M J Cork, D Thaçi, L F Eichenfield, Peter D Arkwright, X Sun, Z Chen, Bolanle Akinlade, S Boklage, I Guillemin, M P Kosloski, M A Kamal, J T O'Malley, N Patel, N M H Graham, Ashish Bansal
Dupilumab provides favourable long-term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: results from an open-label phase IIa study and subsequent phase III open-label extension study. The British journal of dermatology 184 (5) (2020)
A S Paller, E C Siegfried, E L Simpson, M J Cork, B Lockshin, M P Kosloski, M A Kamal, J D Davis, X Sun, G Pirozzi, N M H Graham, A Gadkari, Laurent Eckert, M Ruddy, Ashish Bansal
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (2) (2020)
M J Cork, D Thaçi, L F Eichenfield, Peter D Arkwright, T Hultsch, J D Davis, Y Zhang, X Zhu, Z Chen, M Li, M Ardeleanu, A Teper, Bolanle Akinlade, A Gadkari, Laurent Eckert, M A Kamal, M Ruddy, N M H Graham, G Pirozzi, N Stahl, A T DiCioccio, Ashish Bansal
Dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: results from a phase IIa open-label trial and subsequent phase III open-label extension. The British journal of dermatology 182 (1) (2019)